메뉴 건너뛰기
Current Topics in Microbiology and Immunology
Volumn 240, Issue , 1999, Pages 119-138
Feasibility of antibody production in plants for human therapeutic use
Author keywords

[No Author keywords available]
Indexed keywords

ABCIXIMAB; CAPROMAB PENDETIDE IN 111; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B.72.3; NOFETUMOMAB; NOFETUMOMAB MERPENTAN; OKT 3; ONCOSCINT; ONCOTRAC; PALIVIZUMAB; RITUXIMAB; TRASTUZUMAB; UNCLASSIFIED DRUG;
EID: 0032906897     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review
Times cited : (39)
References (11)
  • 1
    • 0029278832 scopus 로고
    • Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome
    • Albert H, Dale EC, Lee E Ow D (1995) Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J 7:649-659
    • (1995) Plant J , vol.7 , pp. 649-659
    • Albert, H.1    Dale, E.C.2    Lee, E.3    Ow, D.4
  • 2
    • 0027462770 scopus 로고
    • Insertional mutagenesis by transposable elements in the mammalian genome
    • Amariglio N, Rechavi G (1993) Insertional mutagenesis by transposable elements in the mammalian genome. Environ Mol Mutagen 21:212-218
    • (1993) Environ Mol Mutagen , vol.21 , pp. 212-218
    • Amariglio, N.1    Rechavi, G.2
  • 3
    • 0030926366 scopus 로고    scopus 로고
    • Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
    • Anderson DR, Grillo-López A, Yarns C, Chambers KS, Hanna N (1997) Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans 25:705-708
    • (1997) Biochem Soc Trans , vol.25 , pp. 705-708
    • Anderson, D.R.1    Grillo-López, A.2    Yarns, C.3    Chambers, K.S.4    Hanna, N.5
  • 4
    • 14744283551 scopus 로고
    • High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker
    • Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10:169-175
    • (1992) Biotechnology , vol.10 , pp. 169-175
    • Bebbington, C.R.1    Renner, G.2    Thomson, S.3    King, D.4    Abrams, D.5    Yarranton, G.T.6
  • 5
    • 84974752904 scopus 로고
    • Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus
    • Bender E, Pilkington GR, Burton DR (1994) Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus. Hum Antibodies Hybridomas 5(1-2):3-8
    • (1994) Hum Antibodies Hybridomas , vol.5 , Issue.1-2 , pp. 3-8
    • Bender, E.1    Pilkington, G.R.2    Burton, D.R.3
  • 7
    • 0026005994 scopus 로고
    • B3(Fv)-PE38KDEL, a single-chain immutoxin that causes complete regression of a human carcinoma in mice
    • Brinkman U, Pai LH, FitzGerald DJ, Willingham M, Pastan I (1991) B3(Fv)-PE38KDEL, a single-chain immutoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA 88:8616-8620
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 8616-8620
    • Brinkman, U.1    Pai, L.H.2    FitzGerald, D.J.3    Willingham, M.4    Pastan, I.5
  • 8
    • 0023503630 scopus 로고
    • Introns increase gene expression in cultured maize cells
    • Callis J, Fromm M, Walbot V (1987) Introns increase gene expression in cultured maize cells. Genes Dev 1:1183-1200
    • (1987) Genes Dev , vol.1 , pp. 1183-1200
    • Callis, J.1    Fromm, M.2    Walbot, V.3
  • 11
    • 0027434029 scopus 로고
    • Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody
    • Co MS, Scheinberg DA, Avdalovic NM, McGraw K, Vasquez M, Caron PC, Queen C (1993) Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody. Mol Immunol 30:1361-1367
    • (1993) Mol Immunol , vol.30 , pp. 1361-1367
    • Co, M.S.1    Scheinberg, D.A.2    Avdalovic, N.M.3    McGraw, K.4    Vasquez, M.5    Caron, P.C.6    Queen, C.7

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.